Diabetes – Liraglutide
This appraisal specific report is a review of the Mixed Treatment Comparison (MTC) analysis provided by the manufacturer of liraglutide in response to the appraisal consultation document (ACD) (April 2010).
NICE appraisal
TA203 Liraglutide for the treatment of type 2 diabetes (October 2010)
DSU report
Liraglutide for the treatment of type 2 diabetes (PDF, 577KB)